Overview
Paul Celano is an Oncologist and a Hematologist in Baltimore, Maryland. Dr. Celano is rated as a Distinguished provider by MediFind in the treatment of Endometrial Cancer. His top areas of expertise are Ovarian Cancer, Testicular Yolk Sac Tumor, Virilizing Ovarian Tumor, and Ovarian Carcinosarcoma.
His clinical research consists of co-authoring 19 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article and participated in 1 clinical trial in the study of Endometrial Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
6715 N Charles St, Baltimore, MD 21204
6569 N Charles St, 505 Ophthalmology Gbmc, Baltimore, MD 21204
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
12 Clinical Trials
LG Health Physicians Gynecologic Oncology
Lori Cory is an Oncologist in Lancaster, Pennsylvania. Dr. Cory is rated as a Distinguished provider by MediFind in the treatment of Endometrial Cancer. Her top areas of expertise are Endometrial Cancer, Cervical Cancer, Malignant Mixed Mullerian Tumor, Lymphadenectomy, and Salpingo-Oophorectomy. Dr. Cory is currently accepting new patients.
Skip Viragh Outpatient Cancer Center
Stéphanie Gaillard is a medical oncologist who specializes in the treatment of gynecologic malignancies. She recently joined the faculty of the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and is their Director of Gynecologic Cancer Trials. Dr. Gaillard earned her medical degree and doctoral degree in cancer biology from Duke University. Following medical school, she underwent residency training in Internal Medicine and fellowship training in Medical Oncology at the Johns Hopkins School of Medicine. Dr. Gaillard’s research focuses on the development of clinical trials aimed at improving outcomes by incorporating promising new biologic, targeted, and immune therapies into standard treatment regimens. Her translational research program focuses on understanding the immune environment associated with gynecologic cancers and mechanisms of resistance to current therapies. Dr. Gaillard is rated as a Distinguished provider by MediFind in the treatment of Endometrial Cancer. Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Tissue Biopsy, and Salpingo-Oophorectomy.
Johns Hopkins Outpatient Center
Dr. Rebecca Stone is an associate professor in the Johns Hopkins Medicine Department of Gynecology and Obstetrics. Her area of clinical expertise is gynecologic cancers, including cervical, uterine, vulvar and ovarian cancer, as well as gestational trophoblastic disease. Dr. Stone is a highly skilled surgeon with expertise in laparoscopic and robotic surgery for gynecologic tumors. She also serves as director of the Gynecology Enhanced Recovery after Surgery initiative, an innovative, multidisciplinary program that improves recovery and healing time after major abdominal surgery, as well as minimizes health care costs for patients. Dr. Stone received her undergraduate degree in biology from the University of Virginia. She earned her medical degree from the University of Virginia School of Medicine, where she subsequently completed her residency in obstetrics and gynecology. Dr. Stone performed a four-year gynecologic oncology fellowship at the University of Texas MD Anderson Cancer Center. She also earned a master’s degree in cancer biology from the University of Texas in 2010. Prior to joining Johns Hopkins, Dr. Stone was an assistant professor at the University of Arkansas for Medical Sciences, where she was one of five gynecologic oncologists serving the entire state. Dr. Stone is internationally recognized for her research pertaining to early diagnosis and treatment of ovarian cancer. She is widely published in the field of gynecologic oncology, with first-author papers in the New England Journal of Medicine and Lancet Oncology, as well as over 40 co-authored manuscripts in peer-reviewed medical journals. She was honored with an award for one of the most influential papers published in the field of obstetrics and gynecology in 2012 and with an Ovarian Cancer Research Fund Grant for “Unplugging Ovarian Cancer from the Power of Platelets.” Dr. Stone strongly believes in a multidisciplinary team approach to gynecologic cancer care. She seeks to provide women with the most advanced and personalized treatment plans while best preserving quality of life. She enjoys working with community providers so that patients are comforted by receiving care close to home. Dr. Stone is rated as a Distinguished provider by MediFind in the treatment of Endometrial Cancer. Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Hysterectomy, and Oophorectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Lymphocytic Leukemia (CLL)Dr. Celano isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Endometrial CancerDr. Celano isDistinguished. Learn about Endometrial Cancer.
- Large-Cell Immunoblastic LymphomaDr. Celano isDistinguished. Learn about Large-Cell Immunoblastic Lymphoma.
- Ovarian CancerDr. Celano isDistinguished. Learn about Ovarian Cancer.
- Ovarian CarcinosarcomaDr. Celano isDistinguished. Learn about Ovarian Carcinosarcoma.
- Paget Disease of the BreastDr. Celano isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Adult Soft Tissue SarcomaDr. Celano isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Breast CancerDr. Celano isAdvanced. Learn about Breast Cancer.
- Chronic B-Cell Leukemia (CBCL)Dr. Celano isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Colorectal CancerDr. Celano isAdvanced. Learn about Colorectal Cancer.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Essential ThrombocythemiaDr. Celano isAdvanced. Learn about Essential Thrombocythemia.
- Experienced
- Adrenal CancerDr. Celano isExperienced. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaDr. Celano isExperienced. Learn about Adrenocortical Carcinoma.
- Adult Immune ThrombocytopeniaDr. Celano isExperienced. Learn about Adult Immune Thrombocytopenia.
- ALK-Positive Non-Small Cell Lung CancerDr. Celano isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anal CancerDr. Celano isExperienced. Learn about Anal Cancer.
- AngiosarcomaDr. Celano isExperienced. Learn about Angiosarcoma.

